Lolium perenne pollen

Identification

Summary

Lolium perenne pollen is an extract from Lolium perenne pollen used in allergy testing.

Brand Names
Oralair 100, Oralair 300, Oralair Children and Adolescents Sample Kit
Generic Name
Lolium perenne pollen
DrugBank Accession Number
DB10389
Background

Lolium perenne pollen is the pollen of the Lolium perenne plant. Lolium perenne pollen is mainly used in allergenic testing.

Type
Biotech
Groups
Approved
Biologic Classification
Allergenics
Allergen Extract
Synonyms
  • Allergenic extract- ryegrass, perennial lolium perenne
  • Lolium perenne
  • Lolium perenne allergenic extract
  • perennial rye grass pollen extract
  • Standardized perennial rye grass pollen

Pharmacology

Indication

Lolium perenne pollen is an allergen extract included in an allergenic testing product called ORALAIR. It is indicated as immunotherapy for the treatment of grass pollen-induced allergic rhinitis with or without conjunctivitis confirmed by positive skin test or in vitro testing for pollen38 specific IgE antibodies for any of the five grass species contained in this product. ORALAIR is approved for use in persons 5 through 65 years of age.1

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Indication TypeIndicationCombined Product DetailsApproval LevelAge GroupPatient CharacteristicsDose Form
Used in combination for diagnostic processAllergic rhinitis due to pollen••••••••••••
Used in combination for diagnostic processAllergic rhinitis due to pollen••••••••••••••••••••••••••
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AcebutololThe risk of a hypersensitivity reaction to Lolium perenne pollen is increased when it is combined with Acebutolol.
AtenololThe risk of a hypersensitivity reaction to Lolium perenne pollen is increased when it is combined with Atenolol.
BenazeprilThe risk or severity of adverse effects can be increased when Benazepril is combined with Lolium perenne pollen.
BetaxololThe risk of a hypersensitivity reaction to Lolium perenne pollen is increased when it is combined with Betaxolol.
BisoprololThe risk of a hypersensitivity reaction to Lolium perenne pollen is increased when it is combined with Bisoprolol.
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Brand Name Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Allergenic Extract - Standardized Grass Pollen - Perennial RyeLiquid100000 unit / mLIntradermal; SubcutaneousGreer Laboratories2000-10-30Not applicableCanada flag
Allergenic Extract - Standardized Grass Pollen - Perennial RyeLiquid10000 unit / mLIntradermal; SubcutaneousGreer Laboratories2015-10-14Not applicableCanada flag
Allergenic Extract - Standardized Perennnial Rye Grass PollenLiquid100000 unit / mLIntradermal; Percutaneous; SubcutaneousAlk Abello, Inc.2009-07-30Not applicableCanada flag
Center-AL - Lolium Perenne PollenInjection, suspension10000 [PNU]/1mLSubcutaneousALK-Abello, Inc.1975-01-152023-05-16US flag
Center-AL - Lolium Perenne PollenInjection, suspension20000 [PNU]/1mLSubcutaneousALK-Abello, Inc.1975-01-15Not applicableUS flag
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
6 Grass MixLolium perenne pollen (20000 [PNU]/1mL) + Agrostis gigantea pollen (20000 [PNU]/1mL) + Dactylis glomerata pollen (20000 [PNU]/1mL) + Festuca pratensis pollen (20000 [PNU]/1mL) + Phleum pratense pollen (20000 [PNU]/1mL) + Poa pratensis pollen (20000 [PNU]/1mL)Injection, solutionSubcutaneousALK-Abello, Inc.1975-01-152023-05-24US flag
6 Grass MixLolium perenne pollen (10000 [PNU]/1mL) + Agrostis gigantea pollen (10000 [PNU]/1mL) + Dactylis glomerata pollen (10000 [PNU]/1mL) + Festuca pratensis pollen (10000 [PNU]/1mL) + Phleum pratense pollen (10000 [PNU]/1mL) + Poa pratensis pollen (10000 [PNU]/1mL)Injection, solutionSubcutaneousALK-Abello, Inc.1975-01-152023-05-24US flag
7 Grass MixLolium perenne pollen (10000 [PNU]/1mL) + Agrostis gigantea pollen (10000 [PNU]/1mL) + Anthoxanthum odoratum (10000 [PNU]/1mL) + Dactylis glomerata pollen (10000 [PNU]/1mL) + Festuca pratensis pollen (10000 [PNU]/1mL) + Phleum pratense pollen (10000 [PNU]/1mL) + Poa pratensis pollen (10000 [PNU]/1mL)Injection, solutionSubcutaneousALK-Abello, Inc.1975-01-152023-05-24US flag
7 Grass MixLolium perenne pollen (20000 [PNU]/1mL) + Agrostis gigantea pollen (20000 [PNU]/1mL) + Anthoxanthum odoratum (20000 [PNU]/1mL) + Dactylis glomerata pollen (20000 [PNU]/1mL) + Festuca pratensis pollen (20000 [PNU]/1mL) + Phleum pratense pollen (20000 [PNU]/1mL) + Poa pratensis pollen (20000 [PNU]/1mL)Injection, solutionSubcutaneousALK-Abello, Inc.1975-01-152023-05-24US flag
7 Standardized Grass Pollen MixLolium perenne pollen (1428.5714 [BAU]/1mL) + Agrostis gigantea pollen (1428.5714 [BAU]/1mL) + Anthoxanthum odoratum pollen (1428.5714 [BAU]/1mL) + Dactylis glomerata pollen (1428.5714 [BAU]/1mL) + Festuca pratensis pollen (1428.5714 [BAU]/1mL) + Phleum pratense pollen (1428.5714 [BAU]/1mL) + Poa pratensis pollen (1428.5714 [BAU]/1mL)SolutionIntradermal; Percutaneous; SubcutaneousGreer Laboratories, Inc.1968-09-15Not applicableUS flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
4T81LB52R0
CAS number
Not Available

References

General References
  1. FDA Approved Drug Products: ORALAIR 6 (Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue Grass Mixed Pollens Allergen Extract) Tablet for Sublingual Use [Link]
PubChem Substance
347910564
RxNav
852819

Clinical Trials

Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package
PhaseStatusPurposeConditionsCountStart DateWhy Stopped100+ additional columns
Not AvailableCompletedNot AvailableAllergic Reaction1somestatusstop reasonjust information to hide

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
SolutionIntradermal; Percutaneous; Subcutaneous
Injection, solutionSubcutaneous
LiquidIntradermal; Subcutaneous10000 unit / mL
LiquidIntradermal; Subcutaneous100000 unit / mL
LiquidIntradermal; Percutaneous; Subcutaneous100000 unit / mL
LiquidSubcutaneous
Injection, suspensionSubcutaneous10000 [PNU]/1mL
Injection, suspensionSubcutaneous20000 [PNU]/1mL
KitSublingual
Kit; tablet, orally disintegratingSublingual
TabletSublingual100 [IR]
TabletSublingual300 [IR]
Tablet, orally disintegratingSublingual
Injection, solutionSubcutaneous10000 [BAU]/1mL
Injection, solutionSubcutaneous100000 [BAU]/1mL
SolutionPercutaneous10000 [BAU]/1mL
SolutionPercutaneous100000 [BAU]/1mL
TabletSublingual
LiquidIntradermal100 unit / mL
LiquidIntradermal1000 unit / mL
SolutionPercutaneous; Subcutaneous10000 unit / mL
SolutionPercutaneous; Subcutaneous100000 unit / mL
Injection, solutionIntradermal
Injection, solutionPercutaneous; Subcutaneous
Injection, solutionIntradermal100 [BAU]/1mL
Injection, solutionIntradermal1000 [BAU]/1mL
Injection, solutionPercutaneous; Subcutaneous10000 [BAU]/1mL
InjectionCutaneous; Intradermal; Subcutaneous100000 [BAU]/1mL
Injection, solutionIntradermal; Subcutaneous10000 [BAU]/1mL
Injection, solutionIntradermal; Subcutaneous100000 [BAU]/1mL
Injection, solutionPercutaneous100000 [BAU]/1mL
Injection, solutionPercutaneous; Subcutaneous100000 [BAU]/1mL
SolutionIntradermal; Percutaneous; Subcutaneous10000 [BAU]/1mL
SolutionIntradermal; Percutaneous; Subcutaneous100000 [BAU]/1mL
Injection, solutionIntradermal; Subcutaneous
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at December 01, 2015 20:03 / Updated at October 03, 2024 04:54